Adstrum Laboratories Profile
Key Indicators
- Authorised Capital ₹ 2.50 Cr
as on 11-12-2024
- Paid Up Capital ₹ 0.60 M
as on 11-12-2024
- Company Age 9 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 18.50 Cr
as on 11-12-2024
- Revenue %
(FY 2018)
- Profit -203.08%
(FY 2018)
- Ebitda -203.08%
(FY 2018)
- Net Worth -10.10%
(FY 2018)
- Total Assets -3.88%
(FY 2018)
About Adstrum Laboratories
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 0.60 M.
The company currently has active open charges totaling ₹18.50 Cr.
Hardikkumar Shah, Geetaben Patel, Himay Parikh, and Eight other members serve as directors at the Company.
- CIN/LLPIN
U24230GJ2015PTC085064
- Company No.
085064
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Nov 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Adstrum Laboratories?
Board Members(11)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hardikkumar Shah  | Director | 12-Aug-2021 | Current |
| Geetaben Patel | Director | 16-Jul-2022 | Current |
| Himay Parikh | Director | 16-Jul-2022 | Current |
| Vandanaben Patel | Director | 16-Jul-2022 | Current |
| Margi Patel | Director | 16-Jul-2022 | Current |
| Pankajkumar Pathar | Director | 16-Jul-2022 | Current |
Financial Performance of Adstrum Laboratories.
Adstrum Laboratories Private Limited, for the financial year ended 2018, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 203.08% decrease in profit. The company's net worth observed a substantial decline by a decrease of 10.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Adstrum Laboratories?
In 2018, Adstrum Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vh Lifecare Private LimitedActive 4 years 9 monthsHardikkumar Shah and Vishal Parikh are mutual person
- Vitals Multi Speciality Hospital Private LimitedActive 2 years 10 months
Hardikkumar Shah and Vishal Parikh are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 29 Jul 2022 | ₹9.25 Cr | Open |
Others Creation Date: 20 Jul 2022 | ₹9.25 Cr | Open |
How Many Employees Work at Adstrum Laboratories?
Unlock and access historical data on people associated with Adstrum Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Adstrum Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Adstrum Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
